S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

NCT06188702 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

MTAP-deleted Solid Tumors

Interventions

DRUG: S095035
DRUG: TNG462

Sponsor

Servier Bio-Innovation LLC

Collaborators

[object Object]
[object Object]